Identification of sites in adenovirus hexon for foreign peptide incorporation. - Wikidata - wikimedia - TriplyDB

Identification of sites in adenovirus hexon for foreign peptide incorporation.

Identification of sites in adenovirus hexon for foreign peptide incorporation.

http://www.wikidata.org/entity/Q33737591

about

CryoEM visualization of an adenovirus capsid-incorporated HIV antigen Derivation of a triple mosaic adenovirus for cancer gene therapy.HIV antigen incorporation within adenovirus hexon hypervariable 2 for a novel HIV vaccine approach.A recombinant adenovirus-based vector elicits a specific humoral immune response against the V3 loop of HIV-1 gp120 in mice through the "Antigen Capsid-Incorporation" strategy.New adenovirus-based vaccine vectors targeting Pfs25 elicit antibodies that inhibit Plasmodium falciparum transmission.Adenovirus receptors and their implications in gene delivery Immunization with Hexon modified adenoviral vectors integrated with gp83 epitope provides protection against Trypanosoma cruzi infection Substitution of adenovirus serotype 3 hexon onto a serotype 5 oncolytic adenovirus reduces factor X binding, decreases liver tropism, and improves antitumor efficacy.Protection against enterovirus 71 with neutralizing epitope incorporation within adenovirus type 3 hexon.Current progress in the development of a prophylactic vaccine for HIV-1.Chapter two--Adenovirus strategies for tissue-specific targeting.Characterization of a permissive epitope insertion site in adenovirus hexon Epitopes expressed in different adenovirus capsid proteins induce different levels of epitope-specific immunity Using multivalent adenoviral vectors for HIV vaccination Hexon modification to improve the activity of oncolytic adenovirus vectors against neoplastic and stromal cells in pancreatic cancer Adenovirus with hexon Tat-protein transduction domain modification exhibits increased therapeutic effect in experimental neuroblastoma and neuroendocrine tumors Utilizing the antigen capsid-incorporation strategy for the development of adenovirus serotype 5-vectored vaccine approaches.A Plasmodium Promiscuous T Cell Epitope Delivered within the Ad5 Hexon Protein Enhances the Protective Efficacy of a Protein Based Malaria Vaccine Oncolytic adenoviruses - selective retargeting to tumor cells.Current advances and future challenges in Adenoviral vector biology and targeting Adenoviral vectors elicit humoral immunity against variable loop 2 of clade C HIV-1 gp120 via "Antigen Capsid-Incorporation" strategy.Optimization of capsid-incorporated antigens for a novel adenovirus vaccine approach.Targeting of adenovirus serotype 5 pseudotyped with short fiber from serotype 41 to c-erbB2-positive cells using bispecific single-chain diabody.Epitope Capsid-Incorporation: New Effective Approach for Vaccine Development for Chagas Disease.Adenoviral vector-based strategies for cancer therapy.Strategies to overcome host immunity to adenovirus vectors in vaccine development.Capsid-incorporation of antigens into adenovirus capsid proteins for a vaccine approach.Prospects for oral replicating adenovirus-vectored vaccines.The evolution of adenoviral vectors through genetic and chemical surface modifications.Tropism-modification strategies for targeted gene delivery using adenoviral vectors.Antitumor Efficacy of SLPI Promoter-Controlled Expression of Artificial microRNA Targeting EGFR in a Squamous Cell Carcinoma Cell Line.Redirecting adenovirus tropism by genetic, chemical, and mechanical modification of the adenovirus surface for cancer gene therapy.Adenovirus targeting to HLA-A1/MAGE-A1-positive tumor cells by fusing a single-chain T-cell receptor with minor capsid protein IX.Characterization of capsid-modified adenovirus vectors containing heterologous peptides in the fiber knob, protein IX, or hexon.An adenovirus vector with a chimeric fiber incorporating stabilized single chain antibody achieves targeted gene delivery.Exploration of New Sites in Adenovirus Hexon for Foreign Peptides Insertion.Construction of a pIX-modified Adenovirus Vector Able to Effectively Bind to Nanoantibodies for Targeting.Clustered epitopes within a new poly-epitopic HIV-1 DNA vaccine shows immunogenicity in BALB/c mice.

P2860

Q27335395-4D1BB3EF-39DD-44CF-9064-68D7EFE9B538 Q33521705-BE9B2B63-C003-47A3-A37A-C43CB00D6E73 Q33646773-AD082203-38BB-4665-831D-28752AB073D4 Q33786140-C7DC4929-C65B-4869-8C5C-81FE76480B37 Q33801989-9BABE54A-53B4-40C3-862F-5F825AB81BE7 Q33994011-A7DFADEA-A8E9-48B3-B445-660A3CFD774B Q34075166-BD5747F5-F7A6-4D8F-9620-D5B88376F175 Q34153846-8A9AED8D-22C1-415B-B196-34CDE3930A3B Q34358402-DEA3729A-EFEC-4808-8FC4-83595564D07D Q34502108-C5795C6F-645C-4AFB-89B7-C08D420FE5D8 Q34643252-E4206086-AB89-400D-805C-895BD7141012 Q34648067-04217884-1D81-4CB4-8DC4-E26DDF9F4C95 Q34648154-2A150858-8D9B-4987-ABB1-8FE406B6CBFD Q34653777-2E24B305-FB2F-465F-89E8-5C84CDA4EC6B Q35096275-7D3074B6-21CE-4894-8541-C73C09A1D3B6 Q35599319-AE7FCE65-E3AD-43DF-A19C-7104B8FEF925 Q35973091-35B58AD3-BAE0-4706-9447-9A3525FA71F8 Q36003208-B712582D-5FC5-4E3C-A875-16AED5E246AC Q36318189-D34B5A4F-6114-4000-8F79-CF516360E0D6 Q36463004-00CB4823-01A8-4CC6-9F61-C2F339F06B78 Q36625165-31319B18-2D56-414F-B48C-CC35BAE77591 Q36873456-BA64E4FC-AAB8-4CE7-B5E5-ECA2BD602122 Q37227135-7D7922DB-D2E7-44C7-8D78-0312B85636D0 Q37304346-1142E8DD-475D-45AB-98EB-C03EC04A36D2 Q37409025-54D6BA9A-10CD-4C23-8BB2-151BCEF000E9 Q37503253-9C731722-9ED7-4895-B73A-997EC643353D Q37806749-7C750A90-308D-4C27-918D-D438A96F1690 Q38109356-C04A5C3F-C89F-49F3-B243-F4BA2EB12D44 Q38189250-F7544CA5-98F3-4CAF-9721-76030097D620 Q38614156-3A09C58B-2CF3-4FA8-AAE8-46B7FCC76CE1 Q38720608-688B754B-DFB7-4765-8D1A-3C9F68DC2814 Q38769919-E5A64FE0-6F18-46F4-84D6-BB26C1DE9B24 Q40005191-C7F5B041-53FC-48AE-BFE4-015B5C178F3F Q40226617-C5F85C19-A126-45A6-9F41-A8B250A8B205 Q40383912-1B5A6EF9-5DE8-47E6-932F-79F97A1534ED Q41165765-E24F36E2-B6B8-4A62-8E8A-394F687ABF7D Q41875163-0004C0E6-3274-4E0D-B725-EDD06D49C6E0 Q42217775-2F69B7A2-B738-42BF-BC73-040B8CE0DAD5

P2860

Identification of sites in adenovirus hexon for foreign peptide incorporation.

http://www.wikidata.org/entity/Q33737591

description

2005 nî lūn-bûn

@nan

2005 թուականի Մարտին հրատարակուած գիտական յօդուած

@hyw

2005 թվականի մարտին հրատարակված գիտական հոդված

@hy

2005年の論文

@ja

2005年学术文章

@wuu

2005年学术文章

@zh-cn

2005年学术文章

@zh-hans

2005年学术文章

@zh-my

2005年学术文章

@zh-sg

2005年學術文章

@yue

name

Identification of sites in adenovirus hexon for foreign peptide incorporation.

@ast

Identification of sites in adenovirus hexon for foreign peptide incorporation.

@en

type

label

Identification of sites in adenovirus hexon for foreign peptide incorporation.

@ast

Identification of sites in adenovirus hexon for foreign peptide incorporation.

@en

prefLabel

Identification of sites in adenovirus hexon for foreign peptide incorporation.

@ast

Identification of sites in adenovirus hexon for foreign peptide incorporation.

@en

P1433

Q33737591-2A23BFB9-D6AB-4779-B5EE-090F4282B6BD

P1476

Q33737591-AEBAE6E5-4EEA-4DD6-88E6-68B7576254A6

P2093

Q33737591-2FBE6AA1-679F-4B1C-A8A8-550C828459D5

Q33737591-5A3D1830-0C24-4A4B-89A6-675E3158E3BD

Q33737591-68B326AC-C026-41A9-B33E-3B256EDA0D6F

Q33737591-8494F005-F5EB-4D1C-8ED6-A6FE1C89910D

Q33737591-8C4AA604-1F36-4645-8295-4BFCE82B95D2

Q33737591-99F85401-D64F-42BF-9FB4-4619493D0DA0

Q33737591-E44E4311-94DF-4494-A736-512786F3C906

Q33737591-E4964817-0A63-4CD3-83D6-F5FEBAC6A310

P2860

Q33737591-05232A12-BA8F-49FB-A851-4AB4A612169B

Q33737591-0583A475-DF2B-406C-9AE5-66E2C4891040

Q33737591-0633FCE8-993E-4B89-A2F0-91B3632CAFD8

Q33737591-0F7F96AE-86E3-462A-9B2A-ADCD710189D1

Q33737591-1043BC66-0F2D-4A79-88E5-D26DDD546E89

Q33737591-1296341C-5018-483A-932A-49EB6DA567F8

Q33737591-218952CB-6A7C-492D-AA56-F6567F8EE6B3

Q33737591-22A8472C-CB16-4A96-8484-EDE055BC6903

Q33737591-24C51AE0-555A-44EC-94D3-A3473E514B27

Q33737591-2A04A377-E52A-4BC9-8C70-CDAA20762FED

P304

Q33737591-04D0E85E-28DC-4EDD-9F5C-42BCE01A8CDA

P31

Q33737591-F89212EC-7F12-4B4A-8CE5-16EF483D0F73

P356

Q33737591-62523313-5AC2-43FC-953E-517BEDCD9452

P433

Q33737591-30B75A3C-1E02-47F1-ACF4-DAAD777F15CF

P478

Q33737591-F26EABF9-460B-434A-A209-A210E6C8265F

P50

Q33737591-C924DD37-D10B-4DAA-860D-A4032D427F15

P577

Q33737591-47CBAF32-2653-4539-A066-20E204E225C9

P698

Q33737591-01589BA7-8EA4-46E7-90F0-E90012C158E7

P921

Q33737591-0B8C44C5-40DE-4836-A4F5-E99F1F6F7B91

P932

Q33737591-F591B30A-3EC9-49E8-8DE8-318C8584804C

P356

JVI.79.6.3382-3390.2005

P1433

Journal of Virology

P1476

Identification of sites in adenovirus hexon for foreign peptide incorporation.

@en

P2093

Elena Kashentseva

http://www.w3.org/2001/XMLSchema#string

Hongju Wu

http://www.w3.org/2001/XMLSchema#string

Igor Dmitriev

http://www.w3.org/2001/XMLSchema#string

Manjula Kataram

http://www.w3.org/2001/XMLSchema#string

Natalya Belousova

http://www.w3.org/2001/XMLSchema#string

Parameshwar J Mahasreshti

http://www.w3.org/2001/XMLSchema#string

Tie Han

http://www.w3.org/2001/XMLSchema#string

Victor Krasnykh

http://www.w3.org/2001/XMLSchema#string

P2860

Differential activation of innate immune responses by adenovirus and adeno-associated virus vectors

Structural and phylogenetic analysis of adenovirus hexons by use of high-resolution x-ray crystallographic, molecular modeling, and sequence-based methods

Isolation of a common receptor for Coxsackie B viruses and adenoviruses 2 and 5

Integrins alpha v beta 3 and alpha v beta 5 promote adenovirus internalization but not virus attachment

The refined crystal structure of hexon, the major coat protein of adenovirus type 2, at 2.9 A resolution.

Three-dimensional structure of the adenovirus major coat protein hexon.

A system for the propagation of adenoviral vectors with genetically modified receptor specificities.

Role of alpha(v) integrins in adenovirus cell entry and gene delivery.

Immune response to recombinant capsid proteins of adenovirus in humans: antifiber and anti-penton base antibodies have a synergistic effect on neutralizing activity.

Circumvention of immunity to the adenovirus major coat protein hexon.

P304

3382-3390

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1128/JVI.79.6.3382-3390.2005

http://www.w3.org/2001/XMLSchema#string

P433

6

http://www.w3.org/2001/XMLSchema#string

P478

79

http://www.w3.org/2001/XMLSchema#string

P50

David T. Curiel

P577

2005-03-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

15731232

http://www.w3.org/2001/XMLSchema#string

P921

P932

1075677

http://www.w3.org/2001/XMLSchema#string